scispace - formally typeset
Search or ask a question

Showing papers by "Raffaele Bruno published in 2017"


Journal ArticleDOI
TL;DR: The trans jugular intrahepatic Porto systemic shunt (TIPS) is no longer viewed as a salvage therapy or a bridge to liver transplantation and is currently indicated for a number of conditions related to portal hypertension with positive results in survival.

102 citations


Journal ArticleDOI
TL;DR: It is demonstrated that the adherence to a personalized, hypocaloric, low-glycaemic, low -saturated fat diet started early in pregnancy prevents GDM occurrence, in women with BMI ≥ 25 kg/m2 .
Abstract: This study aims to determine whether the prescription of a detailed lifestyle programme in overweight/obese pregnant women influences the occurrence of gestational diabetes (GDM), and if this kind of prescription increases the adherence to a healthier lifestyle in comparison to standard care. The study was designed as a randomized controlled trial, with open allocation, enrolling women at 9–12 weeks of pregnancy with a BMI ≥ 25 kg/m2. The women assigned to the Intervention group (I = 96) received a hypocaloric, low-glycaemic, low-saturated fat diet and physical activity recommendations. Those assigned to the Standard Care group (SC = 95) received lifestyle advices regarding healthy nutrition and exercise. Follow-up was planned at the 16th, 20th, 28th and 36th weeks. A total of 131 women completed the study (I = 69, SC = 62). The diet adherence was higher in the I (57.9%) than in the SC (38.7%) group. GDM occurred less frequently in the I (18.8%) than in the SC (37.1%, P = 0.019) group. The adherent women from either groups showed a lower GDM rate (12.5% vs. 41.8%, P 4000 g were significantly lower in I group. The incidence of small for gestational age babies was not different. These findings demonstrate that the adherence to a personalized, hypocaloric, low-glycaemic, low-saturated fat diet started early in pregnancy prevents GDM occurrence, in women with BMI ≥ 25 kg/m2.

69 citations



Journal ArticleDOI
Salvatore Petta1, Marco Marzioni2, Pierluigi Russo, Alessio Aghemo3  +189 moreInstitutions (14)
TL;DR: The findings suggest that the safety and effectiveness of ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin in patients with HCV genotype 1 or 4 infection and cirrhosis at high risk of decompensation in a real-life setting are similar to those reported in clinical trials.

19 citations


Journal ArticleDOI
TL;DR: To assess the Italian treatment experience with DAAs and to respond to unmet needs in treatment optimization of antiviral therapy in specific settings of CHC patients, a group of Italian experts met in Stresa in February 2017.

16 citations


Journal ArticleDOI
TL;DR: The application of antimicrobial stewardship (AMS) rules appears to be the most appropriate strategy to globally manage cirrhotic patients with infectious complications and they represent a unique way to provide both early diagnosis and appropriate therapy.

10 citations


Journal ArticleDOI
TL;DR: Direct-acting antivirals (DAAs) revolutionized hepatitis C virus (HCV) treatment by enabling viral eradication in more than 95% of cases across all genotypes, and two cases illustrating DAA integration in the treatment course of HCV-positive DLBCLs are reported.

10 citations